Topical Tapinarof Reduces Severity of Plaque Psoriasis
Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control
By Physician’s Briefing Staff | December 09, 2021
By Physician’s Briefing Staff | December 09, 2021